Telleria CM

No ORCID on file · 5 papers in corpus · active 2014-2022

Study types

  • article 1
  • review 1

Condition tags

  • endometriosis 2
2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.886533

Epithelial ovarian cancer (EOC) is considered the deadliest gynecological disease and is normally diagnosed at late stages, at which point metastasis has already occurred. Throughout disease progression, EOC will encounter various ecosystem…

2021
Cancer cell international ·doi:10.1186/s12935-021-02306-y

BackgroundUveal melanoma (UM), the most prevalent intraocular tumor in adults, is a highly metastatic and drug resistant lesion. Recent studies have demonstrated cytotoxic and anti-metastatic effects of the antiprogestin and antiglucocortic…

article 2019
Molecular human reproduction ·doi:10.1093/molehr/gaz026

Endometriosis is a chronic gynecological disease, characterized by growth of endometrial tissue in ectopic sites due to alteration of peritoneal homeostasis and deregulation of apoptosis. Here we have examined whether TNFRp55 deficiency mod…

review 2014
Reproduction (Cambridge, England) ·doi:10.1530/rep-14-0416

Antiprogestins constitute a group of compounds, developed since the early 1980s, that bind progesterone receptors with different affinities. The first clinical uses for antiprogestins were in reproductive medicine, e.g., menstrual regulatio…

2014
Journal of ovarian research ·doi:10.1186/1757-2215-7-45

BackgroundAntiprogestin compounds have been shown to be effective in blocking the growth of ovarian cancer cells of different genetic backgrounds. Herein we studied the anti-ovarian cancer effect of a series of antiprogestins sharing the ch…